Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

NEU1 anticorps (AA 188-214)

Cet anticorps anti-NEU1 est un anticorps Lapin Polyclonal détectant NEU1 dans WB. Adapté pour Humain. Ce Primary Antibody a été cité dans 3+ publications.
N° du produit ABIN1881576

Aperçu rapide pour NEU1 anticorps (AA 188-214) (ABIN1881576)

Antigène

Voir toutes NEU1 Anticorps
NEU1 (Sialidase 1 (Lysosomal Sialidase) (NEU1))

Reactivité

  • 51
  • 12
  • 12
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 41
  • 13
Lapin

Clonalité

  • 43
  • 11
Polyclonal

Conjugué

  • 29
  • 8
  • 7
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp NEU1 est non-conjugé

Application

  • 42
  • 23
  • 19
  • 6
  • 5
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)

Clone

RB42166
  • Épitope

    • 7
    • 7
    • 6
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 188-214

    Homologie

    B

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogène

    This NEU1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 188-214 amino acids from the Central region of human NEU1.

    Isotype

    Ig Fraction
  • Indications d'application

    WB: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Date de péremption

    6 months
  • Caciotti, Di Rocco, Filocamo, Grossi, Traverso, dAzzo, Cavicchi, Messeri, Guerrini, Zammarchi, Donati, Morrone: "Type II sialidosis: review of the clinical spectrum and identification of a new splicing defect with chitotriosidase assessment in two patients." dans: Journal of neurology, Vol. 256, Issue 11, pp. 1911-5, (2009) (PubMed).

    Lai, Chen, Wu Chou, Chang, Kao, Huang, Weng, Chen, Hwu, Lu: "A longitudinal study of Taiwanese sialidosis type 1: an insight into the concept of cherry-red spot myoclonus syndrome." dans: European journal of neurology : the official journal of the European Federation of Neurological Societies, Vol. 16, Issue 8, pp. 912-9, (2009) (PubMed).

    Bonten, Campos, Zaitsev, Nourse, Waddell, Lewis, Taylor, dAzzo: "Heterodimerization of the sialidase NEU1 with the chaperone protective protein/cathepsin A prevents its premature oligomerization." dans: The Journal of biological chemistry, Vol. 284, Issue 41, pp. 28430-41, (2009) (PubMed).

  • Antigène

    NEU1 (Sialidase 1 (Lysosomal Sialidase) (NEU1))

    Autre désignation

    NEU1

    Sujet

    The protein encoded by this gene is a lysosomal enzyme that cleaves terminal sialic acid residues from substrates such as glycoproteins and glycolipids. In the lysosome, this enzyme is part of a heterotrimeric complex together with beta-galactosidase and cathepsin A (the latter is also referred to as 'protective protein'). Mutations in this gene can lead to sialidosis, a lysosomal storage disease that can be type 1 (cherry red spot-myoclonus syndrome or normosomatic type), which is late-onset, or type 2 (the dysmorphic type), which occurs at an earlier age with increased severity.

    Poids moléculaire

    45467

    NCBI Accession

    NP_000425

    UniProt

    Q99519

    Pathways

    SARS-CoV-2 Protein Interactome
Vous êtes ici:
Chat with us!